Deciphering the Phospho-Signaling Network Associated with the Linker Region of Multidrug Resistance Protein 1

Area of Science:

• Molecular Biology
• Cancer Research
• Pharmacology

Background:

• ATP-binding cassette subfamily C member 1 (ABCC1) is a crucial efflux pump involved in cancer multidrug resistance.
• Phosphorylation-dependent regulation of ABCC1 activity is poorly understood, representing a significant knowledge gap.
• Understanding ABCC1 regulation is vital for developing strategies to overcome chemotherapy resistance.

Purpose of the Study:

• To elucidate the phosphorylation-dependent regulatory mechanisms of ABCC1.
• To identify key phosphosites and their co-regulatory networks in ABCC1.
• To explore the translational potential of targeting ABCC1 phosphosites for cancer therapy.

Main Methods:

• Large-scale integrative analysis of over 3800 public phosphoproteomic datasets.
• Identification and mapping of Class I phosphosites on ABCC1, focusing on S919 and S930.
• Multilevel statistical filtering and recurrence analysis to define a high-confidence co-regulatory phospho-network.

Main Results:

• Identified 1266 phosphosites in a co-regulatory network with ABCC1, including known interacting partners (PTGES3, FASN, STX4) and drug transporters (ABCC4, SLC16A1, SLC20A2).
• Demonstrated coordinated phosphorylation of ABCC1 with its partners and associated drug transport proteins.
• Linked the ABCC1-centered phospho-network to critical cancer pathways: carcinogenesis, cell-cycle regulation, and drug resistance.

Conclusions:

• Phosphorylation of ABCC1, particularly at S919 and S930, plays a significant role in regulating its function and contributing to cancer drug resistance.
• The identified ABCC1 co-regulatory phospho-network provides a systems-level understanding of its role in cancer biology.
• Targeting ABCC1 linker domain phosphosites offers potential therapeutic strategies to modulate transporter activity and overcome chemoresistance.